Showing results (1601-1610 of 1,946) with videos related to
Sort By:
Pageof 195
Gastroenterology|May 31, 2012
Abnormal initiation and conduction of slow-wave activity in gastroparesis, defined by high-resolution electrical mappingGregory O'Grady, Timothy R Angeli, Peng Du, et al.Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindolesL Chu, J E Hutchins, A E Weber, et al.Biology of Reproduction|February 21, 2009
Identification of a membrane estrogen receptor in zebrafish with homology to mammalian GPER and its high expression in early germ cells of the testisXiaochun Liu, Pei Zhu, Kathy W Y Sham, et al.Journal of Vascular Surgery|September 11, 2007
Ionizing radiation absorption of vascular surgeons during endovascular proceduresPei Ho, Stephen W K Cheng, P M Wu, et al.British Journal of Cancer|December 3, 2013
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potentialR T Bryan, N J Shimwell, W Wei, et al.Neurochemistry International|September 24, 2013
Modulation of endoplasmic reticulum chaperone GRP78 by high glucose in hippocampus of streptozotocin-induced diabetic mice and C6 astrocytic cellsDaniella P K Wong, John M T Chu, Victor K L Hung, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 21, 2022
Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis studyCecilia Berardi, David A Bluemke, Brian A Houston, et al.Plos One|May 7, 2019
Differentiating weight-restored anorexia nervosa and body dysmorphic disorder using neuroimaging and psychometric markersDon A Vaughn, Wesley T Kerr, Teena D Moody, et al.European Urology Oncology|July 7, 2019
Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non-muscle-invasive Bladder CancerNadezda Lipunova, Anke Wesselius, Kar K Cheng, et al.Lancet (London, England)|July 4, 2012
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trialEdwin DeJesus, Jürgen K Rockstroh, Keith Henry, et al.Pageof 195